Home
BBNX
BBNX News

Latest Beta Bionics Inc. Common Stock (BBNX) News on November 16, 2025

GuruFocus.com

17 days ago

Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges

Beta Bionics (BBNX) Valuation Concerns Mount as Forecast Revenue Growth Far Exceeds Market Average

Simply Wall St.

17 days ago

Beta Bionics (BBNX) Valuation Concerns Mount as Forecast Revenue Growth Far Exceeds Market Average

Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10

Simply Wall St.

17 days ago

Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10

MT Newswires

18 days ago

Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating

Beta Bionics (BBNX) Q3 2025 Earnings Transcript

Motley Fool

18 days ago

Beta Bionics (BBNX) Q3 2025 Earnings Transcript

Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks

19 days ago

Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

GlobeNewswire

19 days ago

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

What to Expect from Beta Bionics Inc (BBNX) Q3 2025 Earnings

GuruFocus.com

20 days ago

What to Expect from Beta Bionics Inc (BBNX) Q3 2025 Earnings

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

GlobeNewswire

a month ago

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

MT Newswires

2 months ago

Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18

MT Newswires

2 months ago

Truist Raises Price Target on Beta Bionics to $28 From $21, Keeps Buy Rating

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions

GlobeNewswire

5 months ago

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions

ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors

MedTech Dive

5 months ago

ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration

Zacks

5 months ago

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration

5 things to watch at the ADA’s Scientific Sessions

MedTech Dive

5 months ago

5 things to watch at the ADA’s Scientific Sessions

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

GlobeNewswire

5 months ago

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

Investing.com

5 months ago

Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth

MT Newswires

5 months ago

Truist Securities Initiates Beta Bionics at Buy With $26 Price Target

Beta Bionics CEO, CFO on how to take a company public

MedTech Dive

5 months ago

Beta Bionics CEO, CFO on how to take a company public

MT Newswires

6 months ago

Goldman Sachs Initiates Coverage on Beta Bionics With Neutral Rating, $16 Price Target

MT Newswires

6 months ago

Wolfe Research Initiates Coverage on Beta Bionics With Outperform Rating, $20 Price Target

The medtech IPO window is finally open. Or is it?

MedTech Dive

6 months ago

The medtech IPO window is finally open. Or is it?

GuruFocus.com

6 months ago

Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

GlobeNewswire

6 months ago

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

Beta Bionics to Present at the Bank of America Securities Health Care Conference

GlobeNewswire

7 months ago

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

GlobeNewswire

7 months ago

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

Beta Bionics to Host Investor Event on June 22, 2025

GlobeNewswire

7 months ago

Beta Bionics to Host Investor Event on June 22, 2025

Newly public Beta Bionics reports sales surge; Dexcom hires CCO

MedTech Dive

8 months ago

Newly public Beta Bionics reports sales surge; Dexcom hires CCO

Beta Bionics Announces Board Appointment of Gerard Michel

GlobeNewswire

8 months ago

Beta Bionics Announces Board Appointment of Gerard Michel

MT Newswires

8 months ago

Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

GlobeNewswire

8 months ago

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Monkey

8 months ago

Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

GlobeNewswire

9 months ago

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls

TipRanks

9 months ago

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls

MT Newswires

9 months ago

Baird Initiates Beta Bionics at Neutral With $20 Price Target

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

10 months ago

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Beta Bionics raises $204M in IPO

MedTech Dive

10 months ago

Beta Bionics raises $204M in IPO

Beta Bionics raises $204m to kickstart medtech IPO season

Medical Device Network

10 months ago

Beta Bionics raises $204m to kickstart medtech IPO season

MT Newswires

10 months ago

Beta Bionics Shares Rise in Nasdaq Debut

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

GlobeNewswire

10 months ago

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

Share on Social Networks: